Simulating healthcare quality innovation based on a novel medical treatment: The case of Hepatitis-C in Europe
M Zsifkovits, J Zsifkovits, SW Pickl - Technological Forecasting and Social …, 2016 - Elsevier
In 2014, a novel medication for treating Hepatitis C virus (HCV) infections caused severe
difficulties for European decision makers in the public medical sector. Even though new …
difficulties for European decision makers in the public medical sector. Even though new …
[PDF][PDF] Dietary supplements as a challenge for contemporary public health: scale of the phenomenon, health risk, legal regulations.
A Marzec, M Skrzypek, Z Marzec - Polish Journal of Public Health, 2018 - researchgate.net
The subject of the study is to present the issues of dietary supplements from the perspective
of public health, taking into account definitional problems, the scale of the phenomenon in …
of public health, taking into account definitional problems, the scale of the phenomenon in …
Economic evaluation of minor ailment schemes (MAS) in the UK
P Schneider, AT Renner, J Bobek… - …, 2017 - thieme-connect.com
Objective Self-care is considered as a possibility to empower patients and to achieve
possibly efficiency gains. However, there is a lack of evidence whether, or not, self-care …
possibly efficiency gains. However, there is a lack of evidence whether, or not, self-care …
Why are self-medication opportunities limited in Austria? An interview study and comparison with other countries
NJ Gauld, CA Baumgärtel, SA Buetow - Plos one, 2021 - journals.plos.org
Background Austria has high health resource use compared to similar countries.
Reclassifying (switching) medicines from prescription to non-prescription can reduce …
Reclassifying (switching) medicines from prescription to non-prescription can reduce …